Crystalline Nanosuspensions as Potential Toxicology and Clinical Oral Formulations for BCS II/IV Compounds-Reference-Cited by-同舟云学术

Crystalline Nanosuspensions as Potential Toxicology and Clinical Oral Formulations for BCS II/IV Compounds

Published:2012-06-27 Issue:4 Volume:14 Page:677-687
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Kesisoglou Filippos,Mitra Amitava

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1208/s12248-012-9383-0.pdf

Reference36 articles.

1. Benet LZ, Wu CY. Using a biopharmaceutics drug disposition classification system to predict bioavailability and elimination characteristics of new molecular entities. Somerset: NJDMDG; 2009.

2. Ku MS, Dulin W. A biopharmaceutical classification-based right-first-time formulation approach to reduce human pharmacokinetic variability and project cycle time from first-in-human to clinical proof-of-concept. Pharm Dev Technol. 2012; 17:285–302.

3. Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003;18:113–20.

4. Kesisoglou F, Panmai S, Wu Y. Nanosizing—oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59:631–44.

5. Merisko-Liversidge E, Liversidge GG. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev. 2011;63:427–40.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An approach to enhance drug solubility: fabrication, characterization, and safety evaluation of Felodipine polymeric nanoparticles;Polymer Bulletin;2024-08-28

2. Optimizing Entrectinib Nanosuspension: Quality by Design for Enhanced Oral Bioavailability and Minimized Fast-Fed Variability;BioNanoScience;2024-05-29

3. Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs;Drug Design, Development and Therapy;2024-05

4. Recent developments in the use of nanocrystals to improve bioavailability of APIs;WIREs Nanomedicine and Nanobiotechnology;2024-03

5. Utilizing Molecular Simulations to Examine Nanosuspension Stability;Pharmaceutics;2023-12-28